Denzapine 25 mg Tablets
- Licence status
- Active substances
- Clozapine
- Dosage Form
- Tablet
- Licence number
- PA0126/235/001
- Licence holder
- Clonmel Healthcare Ltd
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- N05AH Diazepines, oxazepines, thiazepines and oxepines, N05AH02 clozapine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- DENZAPINE Official Recommendations: DENZAPINE is associated with a specific risk of agranulocytosis. Any adverse haematological effects should be notified to the Irish Medicines Board. Intrinsic to Denzapine therapy is enrolment with and monitoring by
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 05/09/2008